ÈÈÁÒ×£ºØ | ½ñÄê»á¹ÙÍøµÇÂ¼Èë¿ÚÖÆÒ©¼¯ÍÅÊ¯É¼¼î¼×»ñµÃÃÀ¹úFDA¡°ÓÐÊý¶ù¿Æ¼²²¡¡±Ò©ÎïÈÏ¶¨£¡-½ñÄê»á¹ÙÍøµÇÂ¼Èë¿Ú-ÒøÐÓÒ¶£¬£¬£¬£¬£¬£¬£¬£¬ÂÈµªÆ½"/> ½ñÄê»á¹ÙÍøµÇÂ¼Èë¿Ú-ÒøÐÓÒ¶£¬£¬£¬£¬£¬£¬£¬£¬ÂÈµªÆ½ ÒøÐÓÒ¶,Þ½ÏãÕýÆøË®,Åµ·úÉ³ÐÇ,ÂÈµªÆ½,ÑÎËáÂÈ±ûàº,Ð¡¶ùÖ¹¿ÈÌÇ½¬,Í·æß¿ËÂå¿ÅÁ£,ºìÂÝÃ¹ËØ¿ÅÁ£,Å£»£»£»£»£»£»£»ÇËá¿ÅÁ£,Í´¾Äþ¿ÅÁ£,ÐÂÉú»¯¿ÅÁ£,°¢¹éÑøÑªÌÇ½¬,½ðÒø»¨Â¶"/> ½ñÄê»á¹ÙÍøµÇÂ¼Èë¿Ú-ÒøÐÓÒ¶£¬£¬£¬£¬£¬£¬£¬£¬ÂÈµªÆ½"/> ÈÈÁÒ×£ºØ | ½ñÄê»á¹ÙÍøµÇÂ¼Èë¿ÚÖÆÒ©¼¯ÍÅÊ¯É¼¼î¼×»ñµÃÃÀ¹úFDA¡°ÓÐÊý¶ù¿Æ¼²²¡¡±Ò©ÎïÈÏ¶¨£¡-½ñÄê»á¹ÙÍøµÇÂ¼Èë¿Ú-ÒøÐÓÒ¶£¬£¬£¬£¬£¬£¬£¬£¬ÂÈµªÆ½"/> ½ñÄê»á¹ÙÍøµÇÂ¼Èë¿Ú-ÒøÐÓÒ¶£¬£¬£¬£¬£¬£¬£¬£¬ÂÈµªÆ½ ÒøÐÓÒ¶,Þ½ÏãÕýÆøË®,Åµ·úÉ³ÐÇ,ÂÈµªÆ½,ÑÎËáÂÈ±ûàº,Ð¡¶ùÖ¹¿ÈÌÇ½¬,Í·æß¿ËÂå¿ÅÁ£,ºìÂÝÃ¹ËØ¿ÅÁ£,Å£»£»£»£»£»£»£»ÇËá¿ÅÁ£,Í´¾Äþ¿ÅÁ£,ÐÂÉú»¯¿ÅÁ£,°¢¹éÑøÑªÌÇ½¬,½ðÒø»¨Â¶"/>

½ñÄê»á¹ÙÍøµÇÂ¼Èë¿Ú

Éè¼ÆÔÆ

Í¼Æ¬Ãû³Æ

ÐÂÎÅ×ÊÑ¶

Ê×Ò³

×ÛºÏÐÂÎÅ

µ³Èº¶¯Ì¬

Ô±¹¤ÔË¶¯

ÈÈÁÒ×£ºØ | ½ñÄê»á¹ÙÍøµÇÂ¼Èë¿ÚÖÆÒ©¼¯ÍÅÊ¯É¼¼î¼×»ñµÃÃÀ¹úFDA¡°ÓÐÊý¶ù¿Æ¼²²¡¡±Ò©ÎïÈÏ¶¨£¡

ÈÕÆÚ£º

2024Äê05ÔÂ17ÈÕ 15:53

½ñÄê»á¹ÙÍøµÇÂ¼Èë¿Ú£¨ÒÔÏÂ¼ò³Æ“½ñÄê»á¹ÙÍøµÇÂ¼Èë¿ÚÖÆÒ©”£©ÓÚ2024Äê5ÔÂ1ÈÕÊÕµ½ÃÀ¹úÊ³ÎïÒ©Æ·¼àÊÓ¹ÜÀí¾Ö£¨ÒÔÏÂ¼ò³Æ“FDA”£©µÄÈÏ¶¨º¯£¬£¬£¬£¬£¬£¬£¬£¬¹«Ë¾²úÆ·Ê¯É¼¼î¼×ÓÃÓÚÖÎÁÆÐÂÉú¶ùÈ±ÑõÈ±ÑªÐÔÄÔ²¡£¡£¡£¡£¡£¡£¡£¡£¨HIE£©»ñµÃFDAÊÚÓèµÄ“ÓÐÊý¶ù¿Æ¼²²¡”£¨Rare Pediatric Disease,RPD£©Ò©ÎïÈÏ¶¨¡£¡£¡£¡£¡£¡£¡£¡£

×Ê¸ñÈÏ¶¨ÇéÐÎ

¹«Ë¾ÓÚ2024Äê3ÔÂÏòFDAÌá½»¹ØÓÚÊ¯É¼¼î¼×RPDÒ©ÎïÈÏ¶¨µÄÏà¹ØÉêÇë£¬£¬£¬£¬£¬£¬£¬£¬ÉêÇëºÅRPD-2024-812£¬£¬£¬£¬£¬£¬£¬£¬»ñµÃFDA»Øº¯È·ÈÏ:“ÎÒÃÇÌØ´ËÅú×¼¹óË¾µÄÇëÇó£¬£¬£¬£¬£¬£¬£¬£¬½«ÓÃÓÚÖÎÁÆÐÂÉú¶ùÈ±ÑõÈ±ÑªÐÔÄÔ²¡£¡£¡£¡£¡£¡£¡£¡£¨HIE£©µÄÊ¯É¼¼î¼×Ö¸¶¨Îª¡¶Áª°îÊ³Îï¡¢Ò©Æ·ºÍ»¯×±Æ··¨°¸¡·£¨FD&C·¨°¸£©µÚ529Ìõ(a)(3)£¨21 U.S.C.360ff(a)(4)£©Ëù½çËµµÄ“ÓÐÊý¶ù¿Æ¼²²¡”Ò©Îï¡£¡£¡£¡£¡£¡£¡£¡£”

Ò©Îï»ù±¾ÇéÐÎ

ÐÂÉú¶ù HIE ÊÇÓÉÄÔ×éÖ¯È±ÑõºÍÄÔÑªÁ÷Á¿ïÔÌÒýÆðµÄÒ»ÖÖÐÂÉú¶ùÄÔËðÉË¼²²¡£¬£¬£¬£¬£¬£¬£¬£¬ÏÖÔÚÖÎÁÆ·½·¨°üÀ¨Ö§³ÖÁÆ·¨¡¢¿ØÖÆ¾ªØÊ¡¢ÖÎÁÆÄÔË®Ö×¡¢ÑÇµÍÎÂÖÎÁÆµÈ¡£¡£¡£¡£¡£¡£¡£¡£

Ê¯É¼¼î¼×Ö÷Òª×÷ÓÃ»úÀíÎªÒÒõ£µ¨¼îõ¥Ã¸ÒÖÖÆ£¬£¬£¬£¬£¬£¬£¬£¬Í¬Ê±¾ßÓÐ¿¹Ñ×¡¢¿¹Ñõ»¯Ó¦¼¤ÓëÉñ¾±£»£»£»£»£»£»£»¤µÈ×÷ÓÃ£¬£¬£¬£¬£¬£¬£¬£¬ÊÊÓÃÓÚÁ¼ÐÔÓ°ÏóÕÏ°£¬£¬£¬£¬£¬£¬£¬£¬Ìá¸ß»¼ÕßÖ¸ÏòÓ°Ïó¡¢åÚÏëÑ§Ï°¡¢Í¼Ïñ»ØÒä¡¢ÎÞÒâÒåÍ¼ÐÎÔÙÈÏ¼°ÈËÏñ»ØÒäµÈÄÜÁ¦£¬£¬£¬£¬£¬£¬£¬£¬¶Ô³Õ´ô»¼ÕßºÍÄÔÆ÷ÖÊÐÔ²¡±äÒýÆðµÄÓ°ÏóÕÏ°ÒàÓÐ¸ÄÉÆ×÷ÓÃ£¬£¬£¬£¬£¬£¬£¬£¬ÒàÓÃÓÚÖØÖ¢¼¡ÎÞÁ¦µÄÖÎÁÆ¡£¡£¡£¡£¡£¡£¡£¡£

»ñµÃÃÀ¹úFDA“ÓÐÊý¶ù¿Æ¼²²¡”Ò©Îï×Ê¸ñÈÏ¶¨µÄÓ°Ïì

ÏÖÔÚ¹«Ë¾Ê¯É¼¼î¼×ÖÊÁÏÒ©ÓëÊ¯É¼¼î¼××¢ÉäÒºÒÑÉÏÊÐÏúÊÛ£¬£¬£¬£¬£¬£¬£¬£¬Ê¯É¼¼î¼×¿ØÊÍÆ¬ÒÑ½øÈëÁÙ´²ÊÔÑé½×¶Î¡£¡£¡£¡£¡£¡£¡£¡£±¾´ÎÊ¯É¼¼î¼×ÖÎÁÆÐÂÉú¶ùÈ±ÑõÈ±ÑªÐÔÄÔ²¡Ë³Ó¦Ö¢»ñµÃ FDA“ÓÐÊý¶ù¿Æ¼²²¡”Ò©Îï×Ê¸ñÈÏ¶¨£¬£¬£¬£¬£¬£¬£¬£¬¼ÓËÙÁË¹«Ë¾Ò©Æ·¹ú¼Ê»¯Õ½ÂÔ½á¹¹¡£¡£¡£¡£¡£¡£¡£¡£FDA ÎªÃãÀøÓÐÊý¡¢ÑÏÖØºÍÎ£¼°ÉúÃüµÄ¶ù¿ÆÒ©ÎïµÄ¿ª·¢¶øÉèÁ¢µÄ“ÓÐÊý¶ù¿Æ¼²²¡”Ò©Îï×Ê¸ñÈÏ¶¨£¬£¬£¬£¬£¬£¬£¬£¬ÎªÓÐÊý¡¢ÑÏÖØµÄ¶ù¿ÆÐÂÒ©¿ª·¢Ìá¹©¼¤Àø£¬£¬£¬£¬£¬£¬£¬£¬¹«Ë¾½«ÓÐ»ú»áÔÚ²úÆ·ÑÐ·¢¡¢×¢²áµÈ·½ÃæÏíÊÜÃÀ¹úµÄÕþ²ßÖ§³Ö£¬£¬£¬£¬£¬£¬£¬£¬°üÀ¨ FDA ¹ØÓÚÁÙ´²¿ª·¢µÄÖ¸µ¼¡£¡£¡£¡£¡£¡£¡£¡£ÈôÎ´À´Ê¯É¼¼î¼×ÖÎÁÆÐÂÉú¶ùHIEµÄÐÂÒ©ÉêÇë»ñµÃÅú×¼£¬£¬£¬£¬£¬£¬£¬£¬ÔòÓÐ»ú»áÉêÇë»ñµÃFDAÊÚÓèµÄÓÅÏÈÉóÆÀÈ¯£¨PriorityReview Voucher,PRV£©¡£¡£¡£¡£¡£¡£¡£¡£ÓÅÏÈÉóÆÀÈ¯¿ÉÓÃÓÚ¼ÓËÙÆóÒµÆäËû²úÆ·µÄÐÂÒ©ÉêÇëÉóÆÀÀú³Ì£¬£¬£¬£¬£¬£¬£¬£¬Òà¿É³öÊÛ×ªÈÃ¸øÆäËûÐÂÒ©ÉÏÊÐÉêÇëÈË£¬£¬£¬£¬£¬£¬£¬£¬¸¶ÓëÊÜÈÃ·½²úÆ· FDA ÓÅÏÈÉóÆÀÈ¨Òæ¡£¡£¡£¡£¡£¡£¡£¡£

ÉÏÒ»Ò³

¿Æ¼¼ÔÂ | ½ñÄê»á¹ÙÍøµÇÂ¼Èë¿ÚÖÆÒ©¼¯ÍÅµÚÒ»½ì¡°¿Æ¼¼ÔÂ¡±ÔË¶¯Æô¶¯´ó»áË³ËìÕÙ¿ª

¹¥ÎÞ²»¿Ë£¬£¬£¬£¬£¬£¬£¬£¬¡°Æ¹¡±ÎÞ²»¿° | ½ñÄê»á¹ÙÍøµÇÂ¼Èë¿ÚÖÆÒ©¼¯ÍÅÖ°¹¤Æ¹ÅÒÇò½ÇÖð¾«²ÊÊÕ¹Ù£¡

ÏÂÒ»Ò³

Ïà¹ØÍÆ¼ö

Í¼Æ¬Ãû³Æ

2022/08/22

²»¹Ü¼¸Ëê,¿ìÀÖÍòËê | ºÅÍâ£¡½ñÄê»á¹ÙÍøµÇÂ¼Èë¿ÚÖÆÒ©¼¯ÍÅÔ±¹¤ÉúÈÕ¸£ÀûÕýÔÚÅÉËÍÖÐ£¡

Í¼Æ¬Ãû³Æ

2021/12/28

ÉùÓþ?|?µãÔÞ£¡½ñÄê»á¹ÙÍøµÇÂ¼Èë¿ÚÖÆÒ©¼¯ÍÅÔÙ´ÎÈÙµÇ¡°2021ÖÐ³ÉÒ©ÆóÒµTOP100¡±°ñµ¥

Í¼Æ¬Ãû³Æ

2021/12/28

ÉùÓþ | ½ñÄê»á¹ÙÍøµÇÂ¼Èë¿Ú¼¯ÍÅÉùÓþÉÏ°ñ2021Õã½ÃñÓªÆóÒµ200Ç¿

< 1...56 57 58...93 > Ç°Íù Ò³

Í¼Æ¬Ãû³Æ

ÍøÕ¾½¨Éè£ºÖÐÆó¶¯Á¦ Ì¨ÖÝ

ÓªÒµÖ´ÕÕ

ÕãICP±¸10002622ºÅ-38

ÍøÕ¾µØÍ¼